Cornercap Investment Counsel Inc Meridian Bioscience Inc Transaction History

Cornercap Investment Counsel Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $207,394 - $335,491	-19,062 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $97,077 - $110,220	-6,259 Reduced 24.72%	19,062 $336,000
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $42,055 - $46,303	-2,832 Reduced 10.06%	25,321 $377,000
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $389,560 - $474,247	-28,229 Reduced 50.07%	28,153 $448,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $274,330 - $322,039	-19,879 Reduced 26.07%	56,382 $801,000
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $542 - $632	-40 Reduced 0.05%	76,261 $1.07 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $1.03 Million - $1.09 Million	76,301	76,301 $1.09 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.